Kojima, Kensuke
Sakamoto, Tetsuki
Kasai, Takahiko
Kagawa, Tomoko
Yoon, Hyungeun
Atagi, Shinji
Article History
Received: 16 June 2021
Accepted: 18 August 2021
First Online: 1 September 2021
Competing interests
: S.A. has received research funding from AstraZeneca, MSD, Eli-Lilly, Chugai, Ono, Taiho, Boehringer-Ingelheim, Pfizer, Bristol-Myers Squibb, F. Hoffmann-La Roche, Hisamitsu, Kyowa Hakko Kirin, Novartis Pharma and Thermo Fisher Scientific. The remaining authors have no conflicts of interest to disclose.